Dr. Himisha Beltran

Dr. Himisha Beltran, MD, is a nationally recognized medical oncologist and translational researcher specializing in genitourinary cancers, with a particular focus on advanced and treatment-resistant prostate cancer. She holds a key leadership role as Director of Translational Research in the Department of Medical Oncology at Dana-Farber Cancer Institute and is an Associate Professor of Medicine at Harvard Medical School. Dr. Beltran earned her medical degree from the University of New Mexico School of Medicine, completed her residency at Mount Sinai Medical Center, and pursued fellowship training in medical oncology at Weill Cornell Medical College. Board-certified in internal medicine and medical oncology, she provides expert care to patients with complex prostate and bladder cancers, integrating cutting-edge science with compassionate care.

Renowned for her groundbreaking research in prostate cancer biology, Dr. Beltran has led seminal studies in understanding lineage plasticity, neuroendocrine differentiation, and mechanisms of resistance to hormonal therapies. Her work has significantly advanced the molecular characterization of aggressive prostate cancer subtypes, helping to redefine treatment approaches for patients with metastatic disease. Her research spans the development of circulating tumor DNA profiling, molecular imaging, and novel biomarker-driven therapeutic strategies, with findings published in top-tier journals such as Nature, Cancer Discovery, and Journal of Clinical Oncology.

Beyond her clinical and scientific impact, Dr. Beltran is a dedicated educator and mentor, guiding the next generation of physician-scientists in oncology. She is actively involved in shaping national clinical guidelines, contributes to collaborative research consortia, and serves on multiple scientific advisory boards. With her unwavering commitment to precision medicine, translational discovery, and multidisciplinary cancer care, Dr. Beltran stands as a driving force in the evolution of prostate cancer research and treatment.